Open AccessIdentification of Actionable Genomic Alterations Using Circulating Cell-Free DNA
Author(s) -
Nora Sánchez,
Michael Kahle,
Ann Bailey,
Chetna Wathoo,
Kavitha Balaji,
Mehmet Esat Demirhan,
Dong Yang,
Milind Javle,
Ahmed O. Kaseb,
Cathy Eng,
Vivek Subbiah,
Filip Janků,
Victoria M. Raymond,
Richard B. Lanman,
Kenna Shaw,
Funda MericBernstam
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.19.00017
Subject(s) - identification (biology) , computational biology , genomic dna , dna , cell free fetal dna , biology , genetics , ecology , pregnancy , fetus , prenatal diagnosis
Cell-free DNA (cfDNA) next-generation sequencing is a noninvasive approach for genomic testing. We report the frequency of identifying alterations and their clinical actionability in patients with advanced/metastatic cancer.